Chugai to Participate in Multinational Study of Avastin in Breast Cancer

Chugai Pharmaceutical will participate in a multinational clinical study to be conducted by the Roche Group to investigate the efficacy of the anticancer agent Avastin (bevacizumab) in inoperable or relapsed breast cancer. Since this essentially means repeating a clinical study...read more